OTC Healthcare in New Zealand
Euromonitor International's OTC Healthcare in New Zealand market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 100 | Publication date: Jan 2008
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
A year of limited growth
For the first time during the review period the OTC healthcare market in New Zealand saw slow progress in 2006. This was due to the poor performance of vitamins and dietary supplements, value sales of which suffered from the disappointing results of direct sales. Despite the temporary setback, several products within the market performed well, including OTC obesity, emergency contraception, eye care and digestive remedies.
Consumers increasingly prepared to self-medicate
The improved performance of several products is a clear testament to the dynamism of the supply side – continued rescheduling providing wider OTC choices, and substitution of generics under prescription of semi-ethical medicines creating increased demand for branded products under OTC. Furthermore, OTC healthcare also benefited from a higher prevalence of self-treatment for basic illnesses, and increased consumer adoption of OTC products with preventative benefits.
OTC obesity – the rising star
Obesity products, rescheduled to OTC status last year, demonstrated the most dynamic growth in 2006, highlighting the fact that obesity is an increasing problem in New Zealand. In recent years obesity has overtaken tobacco smoking as a major cause of preventable deaths, and the government has followed Australian footsteps by rescheduling the leading obesity treatment – Orlistat – to OTC status, in order to provide consumers with easy access to one of the ‘blockbuster’ medicines in the local market.
Pharmacies set to regain lost share
Pharmacies not only remained as the leading distribution channel for OTC healthcare products at the end of the review period, but also saw improvements in sales in 2006 despite pressure from supermarkets, which offer OTC products under the general sales status at very competitive prices. This was largely due to the exclusive status of many powerful OTC products, with the regulatory restrictions to sell through pharmacies under the guidance of pharmacy staff. There were government moves to deregulate pharmacy ownership last year, however, majority ownership of pharmacies still remains under a qualified pharmacist.
Consolidation continues
Following the global trend, the OTC healthcare market in New Zealand has faced a rapid phase of consolidation in recent years, despite being highly fragmented. The acquisition of Boots Healthcare New Zealand by Reckitt Benckiser New Zealand in 2005 made the merged entity the leading OTC healthcare company, overtaking the previous leader, Pfizer New Zealand. However, the forthcoming merger between Pfizer New Zealand and Johnson & Johnson Pacific means the current leadership of Reckitt Benckiser New Zealand is likely to be temporary.
Sound and sustainable forecast
Over the forecast period, Euromonitor forecast that sales of OTC healthcare products in New Zealand will increase gradually, benefiting from the convergence of a number of critical factors, including the recovery of vitamin and dietary supplement sales, as well as changing consumer attitudes towards self-medication. Although an increasing number of medicines are likely to be available on an OTC basis over the forecast period, innovation will play a crucial role within basic, mature product niches, due a high level of competition.
Table of contents
OTC HEALTHCARE IN NEW ZEALAND : MARKET INSIGHT
EXECUTIVE SUMMARY
A year of limited growth
Consumers increasingly prepared to self-medicate
OTC obesity – the rising star
Pharmacies set to regain lost share
Consolidation continues
Sound and sustainable forecast
KEY TRENDS AND DEVELOPMENTS
De-regulations encourage consumers for self-medication
Pharmacies fighting back to secure top position in OTC retailing
Ageing population stimulates OTC sales
Continually changing face of OTC environment
Preventive measures key to shaping demand for OTC healthcare products
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Generics
Consumer Expenditure on Health Goods and Medical Services
Consumer Expenditure on Health Goods and Medical Services
Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - NEW ZEALAND
APOTEX NZ LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Apotex NZ Ltd: Key Facts
Summary 3 Apotex NZ Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Apotex NZ Ltd: Competitive Position 2006
DOUGLAS PHARMACEUTICALS LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Douglas Pharmaceuticals Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 6 Douglas Pharmaceuticals Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 7 Douglas Pharmaceuticals Ltd: Competitive Position 2006
EBOS LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Ebos Group Ltd: Key Facts
Summary 9 Ebos Group Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Ebos Group Ltd: Competitive Position 2006
HEALTHERIES OF NEW ZEALAND LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Healtheries of New Zealand Ltd: Key Facts
Summary 12 Healtheries of New Zealand Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 13 Healtheries of New Zealand Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 14 Healtheries of New Zealand Ltd: Competitive Position 2006
LIFE PHARMACY LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 15 Life Pharmacy Ltd: Key Facts
Summary 16 Life Pharmacy Ltd: Operational Indicators
COMPANY BACKGROUND
ANALGESICS IN NEW ZEALAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2001-2006
Table 13 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 14 Herbal vs Standard Topical Analgesics 2001/2006
Table 15 Analgesics Company Shares by Retail Value 2002-2006
Table 16 Analgesics Brand Shares by Retail Value 2003-2006
Table 17 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN NEW ZEALAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 21 Sales of Decongestants by Type: Value 2001-2006
Table 22 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
DIGESTIVE REMEDIES IN NEW ZEALAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 30 Sales of Digestive Remedies by Subsector: Value 2001-2006
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
Table 32 Herbal vs Standard Digestive Remedies 2001/2006
Table 33 Digestive Remedies Company Shares by Retail Value 2002-2006
Table 34 Digestive Remedies Brand Shares by Retail Value 2003-2006
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
MEDICATED SKIN CARE IN NEW ZEALAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 37 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 39 Herbal vs Standard Medicated Skin Care 2001/2006
Table 40 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 41 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 42 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 43 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
Table 44 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 45 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
VITAMINS AND DIETARY SUPPLEMENTS IN NEW ZEALAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 46 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
Table 47 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
Table 48 Sales of Vitamins by Type: Value 2001-2006
Table 49 Sales of Vitamins by Type: % Value Growth 2001-2006
Table 50 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
Table 51 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 52 Vitamins Brand Shares by Retail Value 2003-2006
Table 53 Sales of Dietary Supplements by Type: Value 2001-2006
Table 54 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
Table 55 Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
Table 57 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
NRT SMOKING CESSATION AIDS IN NEW ZEALAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 58 Number of Smokers by Gender 2001-2006
SECTOR DATA
Table 59 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
Table 60 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
Table 61 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
Table 62 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
Table 63 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011
EYE CARE IN NEW ZEALAND
TRENDS
SECTOR DATA
Table 65 Sales of Eye Care by Subsector: Value 2001-2006
Table 66 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 67 Eye Care Company Shares by Retail Value 2002-2006
Table 68 Eye Care Brand Shares by Retail Value 2003-2006
Table 69 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 70 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
EAR CARE IN NEW ZEALAND
TRENDS
ADULT MOUTHCARE IN NEW ZEALAND
TRENDS
CALMING AND SLEEPING PRODUCTS IN NEW ZEALAND
TRENDS
WOUND TREATMENTS IN NEW ZEALAND
SECTOR DATA
Table 71 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 72 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 73 Wound Treatments Company Shares by Retail Value 2002-2006
Table 74 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 75 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 76 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
OTC OBESITY IN NEW ZEALAND
TRENDS
SECTOR DATA
Table 77 Sales of OTC Obesity by Subsector: Value 2004-2006
Table 78 Sales of OTC Obesity by Subsector: % Value Growth 2004-2006
Table 79 Forecast Sales of OTC Obesity by Subsector: Value 2006-2011
Table 80 Forecast Sales of OTC Obesity by Subsector: % Value Growth 2006-2011
EMERGENCY CONTRACEPTION IN NEW ZEALAND
SECTOR DATA
Table 81 Sales of Emergency Contraception by Subsector: Value 2001-2006
Table 82 Sales of Emergency Contraception by Subsector: % Value Growth 2001-2006
Table 83 Forecast Sales of Emergency Contraception by Subsector: Value 2006-2011
Table 84 Forecast Sales of Emergency Contraception by Subsector: % Value Growth 2006-2011